Amarin Corp Plc (AMRN)

[everyonesguess]

It is FEB now.

Guess on Feb 17: settlement disclosure

NCE determined and listing on OB. No P-IV ANDA can be accepted prior to July 27, and 30 months stay applying to any accepted P-IV ANDA.

If p<0.05 is proven by INTERIM, FREDUCE-IT "tentative success"can be announced (instead to announcing "completion"), and ANCHOR label expansion should be preliminarily granted, but AMRN should continue the study with a modified protocol -- merge placebo arm to active arm till 1,216 CAD events. Prominent approval of ANCHOR Label should be grated upon its success.

INTERIM success should trigger a prioritized review of REDUCE-IT.